Aptargroup

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptargroup and other ETFs, options, and stocks.

About ATR

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty, Closures, and Corporate and Other.

CEO

Stephan B. Tanda

CEOStephan B. Tanda

Employees

14,000

Employees14,000

Headquarters

Crystal Lake, Illinois

HeadquartersCrystal Lake, Illinois

Founded

1940

Founded1940

Employees

14,000

Employees14,000

ATR Key Statistics

Market cap

7.86B

Market cap7.86B

Price-Earnings ratio

21.20

Price-Earnings ratio21.20

Dividend yield

1.49%

Dividend yield1.49%

Average volume

557.88K

Average volume557.88K

High today

$124.21

High today$124.21

Low today

$121.76

Low today$121.76

Open price

$123.08

Open price$123.08

Volume

381.34K

Volume381.34K

52 Week high

$164.28

52 Week high$164.28

52 Week low

$103.23

52 Week low$103.23

Stock Snapshot

As of today, Aptargroup(ATR) shares are valued at $121.99. The company's market cap stands at 7.86B, with a P/E ratio of 21.20 and a dividend yield of 1.5%.

On 2026-03-28, Aptargroup(ATR) stock moved within a range of $121.76 to $124.21. With shares now at $121.99, the stock is trading +0.2% above its intraday low and -1.8% below the session's peak.

Trading activity shows a volume of 381.34K, compared to an average daily volume of 557.88K.

Over the past 52 weeks, Aptargroup(ATR) stock has traded between a high of $164.28 and a low of $103.23.

ATR News

Simply Wall St 12h

Assessing AptarGroup Valuation After Recent Share Price Weakness

Advertisement Why AptarGroup is on investors’ radar today AptarGroup (ATR) has attracted attention after recent share price moves, with a month return of abou...

Simply Wall St 3d

Did CEO Succession and Nasal Drug Collaborations Just Shift AptarGroup's Investment Narrative?

AptarGroup recently announced several developments, including CEO succession planned for September 2026 and new collaborations where its nasal delivery systems...

Simply Wall St 6d

AptarGroup’s Nasal Devices Gain Ground In Respiratory Trials And Leadership Shift

AptarGroup's Unidose Powder Nasal Spray System is being used in ENA Respiratory's Phase II trial for INNA-051. The trial targets prevention of symptomatic vira...

Analyst ratings

70%

of 10 ratings

Buy

70%

Hold

30%

Sell

People also own

Based on the portfolios of people who own ATR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.